AstraZeneca, Sputnik V makers respond to Telangana vaccine tender
File Photo

AstraZeneca and the manufacturers of Sputnik V have responded to Telangana government's invitation for global tenders, said Srinivasa Rao, Director of Public Health. The two companies are in negotiations with the Telangana State Medical Services Infrastructure Development Corporation (TSMIDC), and are likely to arrive at a decision by June 4, said Srinivasa Rao.

Amid shortage of vaccines, the Telangana government had recently invited global tenders to procure 10 million COVID-19 vaccine doses from foreign vaccine manufacturers or their agents in case of imported vaccines. The pre-bid meeting was held on May 26.

The last date to submit the quotation is June 4.

"Representatives of AstraZeneca and Sputnik V participated, though some trade representatives also took part in the pre-bid meeting," sources close to the development told PTI.

The bidders can quote their offers to supply the vaccine in part also, provided that monthly supply shall not be less than 1.5 million and the total supply of 10 million doses shall be completed within six months from the issuance of Letter of Intent (LoI), according to the tender document.

AstraZeneca sells two COVID-19 vaccines. It tied up with Serum Institute and rolled out Covishield in India while it sells the jab under brand name Vaxzevria in Europe and other countries.

Russian Direct Investment Fund inked a pact with Dr Reddy's Laboratories for the first 125 million people doses (250 million vials) of Sputnik V in India.

Telangana on Thursday reported 3,614 new COVID-19 cases, taking the tally to over 5.67 lakh, while the toll stood at 3207 with 18 more casualties, a government bulletin said.

Greater Hyderabad Municipal Corporation (GHMC) accounted for the most number of cases with 504, followed by Nalgonda (229) and Khammam (228), the bulletin said.

(To receive our E-paper on whatsapp daily, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

Free Press Journal